Concise Analysis of the International Stem Cell Markets - WICU12 HD WSEE Erie, PA News, Sports, Weather and Events

Concise Analysis of the International Stem Cell Markets

  • Chris Lifestyle Category TESTMore>>

  • COPY-Chris Test 2

    Chris Test 2

    Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1More >>
  • Chris Test 1

    Chris Test 1

    Monday, February 6 2012 4:05 PM EST2012-02-06 21:05:06 GMT
    Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, Ireland, February 3, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/2c2thn/stem_cell_markets) has announced the addition of the "Concise Analysis of the International Stem Cell Markets" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells.

Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and hematopoietic disorders. Stem cell fate is determined by both intrinsic regulators and the extra-cellular environment (niche), and their expansion and differentiation ex vivo are generally controlled by growing them in a specific configuration (monolayer or three-dimensional culture). This process, which is vital to enable stem cells to be used for therapeutic purposes, is called differentiation. Differentiation is a process involving unspecialized cells progressing to become specialized cells with restricted developmental potential.

The purpose of this report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods that are currently in use today for preparing and using stem cells. It examines the use of stem cells in developing new therapies for disease.


Key Topics Covered:

1. Overview

2. Biology of Stem Cells

3. Stem Cell Therapy

4. Market Analysis of the Stem Cell Space

5. Strategic Roadmap to Cell Therapy Industry

6. Funding for Regenerative Medicine Research

7. Current Stem Cell Research

8. Company Profiles




Companies Mentioned:

  • Aastrom Biosciences, Inc
  • Advanced Cell Technology, Inc
  • Aldagen, Inc
  • Alseres Pharmaceuticals, Inc
  • Amgen, Inc
  • Amorcyte, Inc
  • Angioblast Systems, Inc
  • Asterand plc
  • Athersys, Inc
  • BD Biosciences
  • BioE, Inc
  • BioMimetic Therapeutics, Inc
  • Bioheart, Inc
  • Biosafe Group SA
  • Brainstorm Cell Therapeutics, Inc
  • Cardio3 BioSciences
  • ES Cell International Pvt, Ltd
  • Forticell Bioscience, Inc
  • Gamida Cell
  • GenVec, Inc
  • Geron Corporation
  • Glycosan Biosystems, Inc
  • Humacyte, Inc
  • Integra LifeSciences Holding, Corp
  • Intercytex Group plc
  • International Stem Cell Corporation
  • Japan Tissue Engineering Co., Ltd
  • Life Technologies Corporation
  • LifebankUSA
  • Lonza
  • MedCell Bioscience, Ltd
  • Medistem, Inc
  • Mesoblast Limited
  • Millipore Corporation
  • Miltenyi Biotec
  • Neostem, Inc
  • NeuralStem, Inc
  • NeuroGeneration
  • Novocell, Inc
  • Opexa Therapeutics, Inc
  • OrCel®
  • Organogenesis, Inc
  • Orthovita, Inc
  • Osiris Therapeutics, Inc
  • Pervasis Therapeutics, Inc
  • Pleuron Corp
  • Pluristem Therapeutics, Inc
  • ReNeuron Group Plc
  • Regenocyte Therapeutic
  • Reinnervate LLC
  • Saneron Therapeutics, Inc
  • Scikon Innovation, Inc
  • Stem Cell Sciences KK
  • Stem Cell Therapy International, Inc
  • Stem Cells, Inc
  • StemCell Technologies, Inc
  • Stempeutics Research Private Limited
  • Tengion, Inc
  • TheraVitae
  • VistaGen Therapeutics, Inc
  • ZenBio, Inc


For more information visit http://www.researchandmarkets.com/research/2c2thn/stem_cell_markets


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
3514 State St. Erie, PA 16508
Newsroom: (814)454-8812
Toll Free: 1(800)454-8812
Business offices: (814)454-5201
WICU FCC Filing
WSEE FCC Filing
Share:
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
Mobile:
Mobile Site
Be sure to stay constantly updated with the power of WICU12 and WSEE at your fingertips
Free Android App
Free iPhone App
Free iPad App
Storm Tracker App
Droid
iPhone
iPad
All content © Copyright 2000 - 2014 WorldNow and WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 - info@wicu12.com